BMO Capital Upgrades Bristol-Myers Squibb Co. (BMY) to Market Perform Citing More Balanced Risk/Reward
Tweet Send to a Friend
BMO Capital upgraded Bristol-Myers Squibb Co. (NYSE: BMY) from Underperform to Market Perform with a price target of $47.00.Analyst Alex ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
